Dr. Loss joined the company in 2009 from Fresenius Biotech where he served as Vice-President and Head of the Business Unit. Dr. Loss has in addition worked for international, industrial, and consulting companies. He holds a Ph.D. in business economics from the University of St. Gallen, Switzerland.

With more than 20 years of experience in the pharmaceutical industry, Mr. Doucette joined the company in 2018. Previously, he held senior international finance and commercial positions in Wyeth Pharmaceuticals, later acquired by Pfizer Inc. His most recent role was Regional Commercial Director SEE/Turkey/Greece/Israel for Pfizer’s Consumer Healthcare business unit. Mr. Doucette holds a degree in business administration from Vienna University of Economics and Business.

Mr. Hofmann joined Neovii in 2014 where he served as a Head of Production until he has taken over the responsibility as a Managing Director for Neovii Biotech GmbH. He is bringing over 15 years of experience in the development and manufacturing of biological products. Prior to joining Neovii, he held senior leadership positions at Boehringer-Ingelheim, Fresenius Biotech and Sandoz. Mr. Hofmann holds a biotechnology engineer degree from the University of Anhalt, Germany.